CANbridge Pharmaceuticals Inc.
CANbridge Pharmaceuticals Inc. is a China-focused biopharmaceutical company accelerating development and commercialization of specialty healthcare products for orphan diseases and targeted cancers, focusing on products that are unavailable or address medical needs that are underserved in the region. CANbridge has been recognized as a leader in orphan diseases in China. It has a global partnership with WuXi Biologics to develop and commercialize proprietary therapeutics for the treatment of rare genetic diseases. In greater China, it has an exclusive licensing agreement to commercialize Hunterase, an enzyme replacement therapy for the treatment of Hunter syndrome, developed by GC Pharma and marketed in more than ten countries worldwide. CANbridge also has an oncology portfolio, which includes exclusive rights to develop and commercialize Puma Biotechnologys NERLYNX (neratinib), in greater China, as well as rights to other novel candidates.
CANbridge Pharmaceuticals Inc.
CANbridge Pharmaceuticals Inc. is a China-focused biopharmaceutical company accelerating development and commercialization of specialty healthcare products for orphan diseases and targeted cancers, focusing on products that are unavailable or address medical needs that are underserved in the region. CANbridge has been recognized as a leader in orphan diseases in China. It has a global partnership with WuXi Biologics to develop and commercialize proprietary therapeutics for the treatment of rare genetic diseases. In greater China, it has an exclusive licensing agreement to commercialize Hunterase, an enzyme replacement therapy for the treatment of Hunter syndrome, developed by GC Pharma and marketed in more than ten countries worldwide. CANbridge also has an oncology portfolio, which includes exclusive rights to develop and commercialize Puma Biotechnologys NERLYNX (neratinib), in greater China, as well as rights to other novel candidates.
canbridgepharma.com
4 Burlington Woods Dr Burlington, Massachusetts 01803, US
Details
Year founded
2012
Revenue
75M-200M
Employees
201-500
Number of locations
5
NAICS
3254
SIC
2834
Products & Services
Outlines the company's specialized services and operational strengths.
- Hunterase
- Livmarli
- Nerlynx
- Contact us in order to access
Equipment
Provides a detailed list of machinery and tools utilized on the company's premises.
- Gene therapy development equipment
- Enzyme replacement therapy production equipment
- Monoclonal antibody production equipment
- Contact us in order to access
Ramping up production
Indicates the company's current production trend and growth trajectory.
TRUE
Our production algorithm is showing that canbridge pharmaceuticals is ramping up production.
Target industries
Employees working in CANbridge Pharmaceuticals Inc.
Locations (5)
CANbridge Pharmaceuticals Inc.
4 Burlington Woods Dr Burlington, Massachusetts 01803, US
CANbridge Pharmaceuticals Inc.
No.281, Sec. 4, Xinyi Road Room B06, 11F Taipei, Taiwan, TW
CANbridge Pharmaceuticals Inc.
999 West Zhongshan Road Suite 708, Huawen International Mansion Shanghai, CN
CANbridge Pharmaceuticals Inc.
139 Main St Cambridge, Massachusetts 02142, US
CANbridge Pharmaceuticals Inc.
15 Canton Road, Tsim Sha Tsui Unit A131, 16/F, Sun Life Tower, The Gateway, Harbour City Hong Kong, HK
People Also Searched For
Frequently Asked Questions
What services & capabilities does CANbridge Pharmaceuticals Inc. offer?
CANbridge Pharmaceuticals Inc. offers a range of services and capabilities, including Hunterase.
What kind of equipment does CANbridge Pharmaceuticals Inc. use?
CANbridge Pharmaceuticals Inc. uses a variety of equipment, including Gene therapy development equipment.
What are the target industries of CANbridge Pharmaceuticals Inc.?
CANbridge Pharmaceuticals Inc. serves several industries, including the medical industry.
How many locations does CANbridge Pharmaceuticals Inc. operate?
CANbridge Pharmaceuticals Inc. operates from 5 locations.
Where are the headquarters of CANbridge Pharmaceuticals Inc.?
The headquarters of CANbridge Pharmaceuticals Inc. are located in 4 burlington woods drive, burlington, massachusetts 01803, united states.
What is the NAICS code for CANbridge Pharmaceuticals Inc.?
The NAICS code for CANbridge Pharmaceuticals Inc. is 3254.
How many employees does CANbridge Pharmaceuticals Inc. have?
CANbridge Pharmaceuticals Inc. has 216 employees.
What is the official website of CANbridge Pharmaceuticals Inc.?
The official website of CANbridge Pharmaceuticals Inc. is https://www.canbridgepharma.com/.
When was CANbridge Pharmaceuticals Inc. founded?
CANbridge Pharmaceuticals Inc. was founded in 2012.